Ron Cohen, President and CEO at ACORDA THERAPEUTICS INC (ACOR), sold 149,000 shares at $34.25 ($5.1M) on 2013-08-20, disclosed to the SEC on 2013-08-20.
Scheduled sale ($5.1M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.04 | 61,062 | $2.1M | 40.9% |
| 2 | $34.02 | 55,993 | $1.9M | 37.5% |
| 3 | $34.25 | 26,105 | $894K | 17.6% |
| 4 | $34.82 | 5,840 | $203K | 4.0% |
| Total | $34.10 avg | 149,000 | $5.1M | 100% |
| Filing → |
| ACOR | SELL | 2019-12-04 | $8K | — | Filing → |
| ACOR | SELL | 2018-12-06 | $75K | — | Filing → |
| ACOR | BUY | 2017-06-20 | $339K | — | Filing → |